Clinical Trial Update: Gum Arabic as Antioxidant and Anti-inflammatory in Hemodialysis Patients [NA]

View source ↗

Summary

Clinical trial update examining gum arabic as an antioxidant and anti-inflammatory agent in patients with End-Stage Renal Disease; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Gum Arabic (arabic gum)

Snippet

Sponsor: Lamis Kaddam | Conditions: End-Stage Renal Disease | NA | Status: UNKNOWN